In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Nestle floats part of Alcon on NYSE through IPO

Executive Summary

Nestle SA floated 24.99% of its wholly owned eye care business Alcon on the New York Stock Exchange though an initial public offering. The company sold 76.725mm common shares (including the overallotment) at a price of $33, netting approximately $2.41bn.
Deal Industry
  • Medical Devices
  • Pharmaceuticals
    • OTC, Consumer
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies